Showing results (211-220 of 333) with videos related to
Sort By:
Pageof 34
Plos Neglected Tropical Diseases|January 27, 2017
Investigation of a Medieval Pilgrim Burial Excavated from the Leprosarium of St Mary Magdalen Winchester, UKSimon Roffey, Katie Tucker, Kori Filipek-Ogden, et al.Frontiers in Oncology|December 8, 2025
Range quality assurance measurements for clinical and FLASH proton beam therapy using the quality assurance range calorimeterSaad Shaikh, Sonia Escribano-Rodriguez, Raffaella Radogna, et al.JACC. Case Reports|August 15, 2025
Successful Vaginal Birth in Severe Idiopathic Pulmonary Arterial Hypertension: Lessons Learned From a Cardio-Obstetric ChallengeAshley Hesson, Meghan Horn, Allison Janda, et al.Journal of Clinical Microbiology|November 6, 2004
Microsatellite mapping of Mycobacterium leprae populations in infected humansSaroj K Young, G Michael Taylor, Suman Jain, et al.Resuscitation|January 30, 2013
Tactical and operational response to major incidents: feasibility and reliability of skills assessment using novel virtual environmentsDaniel Cohen, Nick Sevdalis, Vishal Patel, et al.JPEN. Journal of Parenteral and Enteral Nutrition|May 19, 2022
Hybrid model of compounded and multichamber bag parenteral nutrition for adults with chronic intestinal failureSimon Harrison, Maja Kopczynska, Gavin Leahy, et al.Surgery in Practice and Science|January 23, 2025
Reduced rates of pneumonia after implementation of an electronic checklist for the management of patients with multiple rib fractures at a Level One Trauma CenterKevin Yeh, Nicole Spence, Brendin R Beaulieu-Jones, et al.Frontiers in Oncology|May 11, 2026
Correction: Range quality assurance measurements for clinical and FLASH proton beam therapy using the quality assurance range calorimeterSaad Shaikh, Sonia Escribano-Rodriguez, Raffaella Radogna, et al.Molecular Microbiology|September 27, 2014
ADP-ribosylation factor 6 acts as an allosteric activator for the folded but not disordered cholera toxin A1 polypeptideTuhina Banerjee, Michael Taylor, Michael G Jobling, et al.Archives of Pathology & Laboratory Medicine|November 27, 2014
Comparison of anti-Xa and dilute Russell viper venom time assays in quantifying drug levels in patients on therapeutic doses of rivaroxabanRobert C Gosselin, Dorothy M Adcock Funk, J Michael Taylor, et al.Pageof 34